Scotiabank sees ‘deep worth’ in Sage Therapeutics inventory regardless of research setback By Investing.com
On Wednesday, Scotiabank adjusted its outlook on Sage Therapeutics (NASDAQ:SAGE), decreasing the…
Search
Have an existing account?
Sign In
